Introduction
Experimental
Results
| ROS | Groups | ||||
|---|---|---|---|---|---|
| 60 min | 45 min | 30 min | 15 min | 5 5min | |
| Skin | |||||
| 29±2 | 20±2 | 10±3 | 2±1 | 0±1 | Control |
| 59±8 | 44±7 | 34±5 | 18±4 | 3±1 | +CSE (1%) |
| 154±13*** | 141±9*** | 129±11*** | 125±7*** | 23±5*** | +CSE (10%) |
| 292±23*** | 284±14*** | 266±18*** | 255±14*** | 29±5*** | + CSE (100%) |
| Liver | |||||
| 14±2 | 9±2 | 4±3 | 2±1 | 0±1 | Control |
| 29±3* | 24±5* | 21±6* | 18±1** | 3±2 | +CSE (1%) |
| 59±9** | 56±9*** | 51±12*** | 49±6*** | 14±4* | +CSE (10%) |
| 88±18*** | 80±11*** | 79±8*** | 75±9*** | 23±7*** | + CSE (100%) |
P<0.05;
P<0.01;
P<0.001 compared with control mitochondria at the same time interval.
P<0.05;
P<0.01;
P<0.001 compared with control mitochondria.
| MDA(μg/mg protein) | Groups | |
|---|---|---|
| skin | Liver | |
| 3.89±1.54 | 4.82±1.82 | Control |
| 7.94±1.28 | 8.05±1.97 | +CSE (1%) |
| 13.82±0.93** | 15.77±0.96** | +CSE (10%) |
| 17.14±1.07*** | 27.30±0.86*** | + CSE (100%) |
P<0.05 compared with control mitochondria.
| GSH(μg/mg protein) | Groups | |
|---|---|---|
| Skin | Liver | |
| 13.68±0.48 | 54.07±0.50 | Control |
| 9.07±1.06*** | 37.96±1.01** | +CSE (1%) |
| 7.43±1.10*** | 29.67±0.78*** | +CSE (10%) |
| 4.27±0.94*** | 24.67±0.49*** | + CSE (100%) |
P<0.05 compared with control mitochondria.
| ∆Ψ% | Groups | ||||
|---|---|---|---|---|---|
| 60 min | 45 min | 30 min | 15 min | 5 5min | |
| Skin | |||||
| 21±2 | 21±4 | 17±5 | 13±1 | 0±2 | Control |
| 41±5** | 35±8 | 26±4 | 21±5 | 4±1* | +CSE (1%) |
| 58±4*** | 55±11* | 48±7*** | 42±16 | 13±1*** | +CSE (10%) |
| 66±7*** | 61±13** | 59±2*** | 57±18* | 22±1*** | + CSE (100%) |
| Liver | |||||
| 45±2 | 31±1 | 21±5 | 14±2 | 0±1 | Control |
| 147±11*** | 86±8*** | 58±3** | 17±4 | 1±1 | +CSE (1%) |
| 149±15*** | 94±9*** | 63±9*** | 22±5 | 5±2 | +CSE (10%) |
| 138±13*** | 97±7*** | 86±10*** | 22±3 | 6±3 | + CSE (100%) |
P<0.05;
P<0.01;
P<0.001 compared with control mitochondria.
| Mitochondrial Swelling percent (%) | Groups | ||||
|---|---|---|---|---|---|
| 60 min | 45 min | 30 min | 15 min | 5 min | |
| Skin | |||||
| 21±2 | 21±4 | 17±5 | 13±1 | 0±2 | Control |
| 41±5** | 35±8 | 26±4 | 21±5 | 4±1 | +CSE (1%) |
| 58±4*** | 55±11* | 48±7*** | 42±16 | 3±1 | +CSE (10%) |
| 66±7*** | 61±13** | 59±2*** | 57±18* | 4±3 | + CSE (100%) |
| Liver | |||||
| 5±2 | 3±1 | 2±1 | 1±1 | 0±1 | Control |
| 17±2*** | 16±1*** | 13±4 | 11±2* | 6±2 | +CSE (1%) |
| 41±2*** | 40±2*** | 40±4** | 30±4*** | 29±2*** | +CSE (10%) |
| 73±1*** | 72±4*** | 71±15*** | 69±4*** | 69±9*** | + CSE (100%) |
P<0.05;
P<0.01;
P<0.001 compared with control mitochondria.
P<0.01;
P<0.001 compared with control mitochondria.
| Cytochrome C release ( ng/mg protein ) | Groups | |
|---|---|---|
| Skin | Liver | |
| 42±17 | 42±11 | Control |
| 50±24 | 88±17** | +CSE (1%) |
| 101±20* | 152±30*** | +CSE (10%) |
| 166±8*** | 254±23*** | + CSE (100%) |
| 84±5 | 92±43 | +CSE (10%) +BHT |
| 80±4 | 98±40 | +CSE (10%) +CsA |
P<0.05 compared with control mitochondria.